Atherosclerotic carotid disease. Experience at the National Institute of Neurology and Neurosurgery in patients undergoing carotid angioplasty with stent

Authors

  • Juan Manuel Santana-López
  • Marco Antonio Zenteno-Castellanos
  • Jorge Balderrama-Bañares
  • Liliana Escobar-Pérez
  • Susana Vega-Montesinos

DOI:

https://doi.org/10.31157/an.v19i3.47

Keywords:

carotid atherosclerotic disease, angioplasty, stent, cerebral ischemia.

Abstract

The carotid atherosclerotic disease (CD) is a common global entity, with a prevalence of approximately 55 to 60%, being more frequent in patients over 60 years, with no significant differences between gender. The moderate-severe CAD (stenosis> 50%) accounts for about 15% of cases of stroke and up to 50% of transient ischemic episodes. It also identified by carotid bruits in asymptomatic persons (without presenting symptoms of cerebral ischemia). Treatment consisting of antiplatelet, statin use and control of risk factors; but sometimes invasive treatment (endarterectomy vs stenting) is required. Carotid angioplasty may be superior to carotid endarterectomy in a group of patients, such as those previously undergone neck surgery or radiation.

Published

2014-09-01

How to Cite

Santana-López, J. M., Zenteno-Castellanos, M. A., Balderrama-Bañares, J., Escobar-Pérez, L., & Vega-Montesinos, S. (2014). Atherosclerotic carotid disease. Experience at the National Institute of Neurology and Neurosurgery in patients undergoing carotid angioplasty with stent. Archivos De Neurociencias, 19(3), 137–146. https://doi.org/10.31157/an.v19i3.47

Issue

Section

Original Articles

Most read articles by the same author(s)